BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3512343)

  • 1. Reduction by morphine of human postprandial insulin release is secondary to inhibition of gastrointestinal motility.
    Sullivan SN; Lee MG; Bloom SR; Lamki L; Dupré J
    Diabetes; 1986 Mar; 35(3):324-8. PubMed ID: 3512343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric emptying and release of incretin hormones after glucose ingestion in humans.
    Schirra J; Katschinski M; Weidmann C; Schäfer T; Wank U; Arnold R; Göke B
    J Clin Invest; 1996 Jan; 97(1):92-103. PubMed ID: 8550855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of insulin, glucagon-like peptide 1, gastric inhibitory polypeptide, and appetite in response to intraduodenal carbohydrate.
    Lavin JH; Wittert GA; Andrews J; Yeap B; Wishart JM; Morris HA; Morley JE; Horowitz M; Read NW
    Am J Clin Nutr; 1998 Sep; 68(3):591-8. PubMed ID: 9734735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of physiological hyperglycemia on duodenal motility and flow events, glucose absorption, and incretin secretion in healthy humans.
    Kuo P; Wishart JM; Bellon M; Smout AJ; Holloway RH; Fraser RJ; Horowitz M; Jones KL; Rayner CK
    J Clin Endocrinol Metab; 2010 Aug; 95(8):3893-900. PubMed ID: 20501683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intraduodenal glutamine on incretin hormone and insulin release, the glycemic response to an intraduodenal glucose infusion, and antropyloroduodenal motility in health and type 2 diabetes.
    Chang J; Wu T; Greenfield JR; Samocha-Bonet D; Horowitz M; Rayner CK
    Diabetes Care; 2013 Aug; 36(8):2262-5. PubMed ID: 23564914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of metoclopramide on duodenal motility and flow events, glucose absorption, and incretin hormone release in response to intraduodenal glucose infusion.
    Kuo P; Bellon M; Wishart J; Smout AJ; Holloway RH; Fraser RJ; Horowitz M; Jones KL; Rayner CK
    Am J Physiol Gastrointest Liver Physiol; 2010 Dec; 299(6):G1326-33. PubMed ID: 20829521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of intraduodenal glucose and fructose on antropyloric motility and appetite in healthy humans.
    Rayner CK; Park HS; Wishart JM; Kong M; Doran SM; Horowitz M
    Am J Physiol Regul Integr Comp Physiol; 2000 Feb; 278(2):R360-6. PubMed ID: 10666136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of secretion of gastric inhibitory polypeptide and insulin by intraduodenal amino acid perfusion.
    Thomas FB; Mazzaferri EL; Crockett SE; Mekhjian HS; Gruemer HD; Cataland S
    Gastroenterology; 1976 Apr; 70(4):523-7. PubMed ID: 815125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of naloxone and morphine on postprandial gastrointestinal hormone secretion.
    Champion MC; Sullivan SN; Bloom SR; Adrian TE; Christofides ND
    Am J Gastroenterol; 1982 Sep; 77(9):617-20. PubMed ID: 7051818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of glucose-dependent insulinotropic polypeptide on gastric emptying, glycaemia and insulinaemia during critical illness: a prospective, double blind, randomised, crossover study.
    Kar P; Cousins CE; Annink CE; Jones KL; Chapman MJ; Meier JJ; Nauck MA; Horowitz M; Deane AM
    Crit Care; 2015 Jan; 19(1):20. PubMed ID: 25613747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of intraduodenal fat and glucose on the gut-incretin axis in healthy males.
    Wu T; Rayner CK; Watson LE; Jones KL; Horowitz M; Little TJ
    Peptides; 2017 Sep; 95():124-127. PubMed ID: 28800948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans.
    Schirra J; Nicolaus M; Roggel R; Katschinski M; Storr M; Woerle HJ; Göke B
    Gut; 2006 Feb; 55(2):243-51. PubMed ID: 15985560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The priming effect of glucose on the gastric inhibitory polypeptide-induced insulin release.
    Jorde R; Amland PF; Burhol PG
    Scand J Gastroenterol; 1986 Jan; 21(1):47-50. PubMed ID: 3513294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of variations in duodenal glucose load on glycaemic, insulin, and incretin responses in type 2 diabetes.
    Ma J; Pilichiewicz AN; Feinle-Bisset C; Wishart JM; Jones KL; Horowitz M; Rayner CK
    Diabet Med; 2012 May; 29(5):604-8. PubMed ID: 22004512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of graded intraduodenal glucose infusions on the release and physiological action of gastric inhibitory polypeptide.
    McCullough AJ; Miller LJ; Service FJ; Go VL
    J Clin Endocrinol Metab; 1983 Feb; 56(2):234-41. PubMed ID: 6337173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of subcutaneous GLP-1 on gastric emptying, antroduodenal motility, and pancreatic function in men.
    Schirra J; Kuwert P; Wank U; Leicht P; Arnold R; Göke B; Katschinski M
    Proc Assoc Am Physicians; 1997 Jan; 109(1):84-97. PubMed ID: 9010920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of atropine on plasma gastric inhibitory polypeptide (GIP), serum insulin, and blood glucose after intraduodenal infusion of fat.
    Jorde R; Burhol PG; Waldum HL
    Scand J Gastroenterol; 1981 Apr; 16(3):331-6. PubMed ID: 16435472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xylitol vs glucose: effect on the rate of gastric emptying and motilin, insulin, and gastric inhibitory polypeptide release.
    Salminen EK; Salminen SJ; Porkka L; Kwasowski P; Marks V; Koivistoinen PE
    Am J Clin Nutr; 1989 Jun; 49(6):1228-32. PubMed ID: 2658536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7-36) amide infused at near-physiological insulinotropic hormone and glucose concentrations.
    Nauck MA; Bartels E; Orskov C; Ebert R; Creutzfeldt W
    J Clin Endocrinol Metab; 1993 Apr; 76(4):912-7. PubMed ID: 8473405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects.
    Chaikomin R; Doran S; Jones KL; Feinle-Bisset C; O'Donovan D; Rayner CK; Horowitz M
    Am J Physiol Endocrinol Metab; 2005 Sep; 289(3):E504-7. PubMed ID: 15886226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.